UNSPSC 51172415: Amylase/atropine/lipase/protease

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA500. This VA Drug Class (GA500) classifies this compound as belonging to the group DIGESTANTS.

UNSPSC 51172415 Amylase/atropine/lipase/protease is a Commodity code that encompasses enzyme and pharmaceutical products used in diagnostic testing, specimen screening, and direct-to-manufacturer prescription programs serving state and local health and corrections agencies. State and local governments buy these products primarily through two channels: as component inputs in clinical laboratory and drug-screening operations (immunoassay and confirmatory testing reagents), and as finished pharmaceutical products distributed through cooperative purchasing agreements to correctional, health, and social-service facilities. The issuing bodies include county corrections departments, state health and human services commissions, and multistate cooperative purchasing alliances administering contracts on behalf of participating state and local agencies. Collin County Community Supervision and Corrections Department and the Texas Health and Human Services Commission represent the active buyers in the recent opportunity set.

Recent activity concentrates in Texas and the Upper Midwest. Collin County's offender drug-testing RFP 2026-327, due July 23, 2026, estimates $600,000 annually for specimen collection and immunoassay screening with LC/MS/MS or GC/MS confirmation across two sites in Plano and McKinney, with a two-year term commencing September 1, 2026 and optional three one-year renewals. The Texas HHS Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs for self-insured health plans, signaling early-stage procurement exploration rather than immediate contracting. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, establishing supplier agreements effective July 1, 2026 for distribution through AmerisourceBergen, Cardinal Health, and Morris & Dickson wholesalers to participating state and local facilities across Minnesota, Oregon, and other member jurisdictions. Evaluation in the Collin County opportunity weights vendor qualifications and client references at 40 points and cost at 30 points, with optional demonstrations and interviews worth up to 30 additional points.